Znanstveni rad - Prikaz slučaja
Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab
Acta clinica Croatica, 62 (2023), 2; 382-385. https://doi.org/10.20471/acc.2023.62.02.19

Krečak, Ivan; Gverić-Krečak, Velka

Citirajte ovaj rad

Krečak, I. i Gverić Krečak, V. (2023). Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab. Acta clinica Croatica, 62. (2), 382-385. doi: 10.20471/acc.2023.62.02.19

Krečak, Ivan i Velka Gverić Krečak. "Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab." Acta clinica Croatica, vol. 62, br. 2, 2023, str. 382-385. https://doi.org/10.20471/acc.2023.62.02.19

Krečak, Ivan i Velka Gverić Krečak. "Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab." Acta clinica Croatica 62, br. 2 (2023): 382-385. https://doi.org/10.20471/acc.2023.62.02.19

Krečak, I. i Gverić Krečak, V. (2023) 'Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab', Acta clinica Croatica, 62(2), str. 382-385. doi: 10.20471/acc.2023.62.02.19

Krečak I, Gverić Krečak V. Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab. Acta clinica Croatica [Internet]. 2023. [pristupljeno 13.07.2024.];62(2):382-385. doi: 10.20471/acc.2023.62.02.19

I. Krečak i V. Gverić Krečak, "Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab", Acta clinica Croatica, vol. 62, br. 2, str. 382-385, 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:287378. [Citirano: 13.07.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.